Human Ischaemic Cascade Studies Using SH-SY5Y Cells: a Systematic Review and Meta-Analysis

Abstract

Low translational yield for stroke may reflect the focus of discovery science on rodents rather than humans. Just how little is known about human neuronal ischaemic responses is confirmed by systematic review and meta-analysis revealing that data for the most commonly used SH-SY5Y human cells comprises only 84 papers. Oxygen-glucose deprivation, H2O2, hypoxia, glucose-deprivation and glutamate excitotoxicity yielded − 58, − 61, − 29, − 45 and − 49% injury, respectively, with a dose-response relationship found only for H2O2 injury (R2 = 29.29%, p < 0.002). Heterogeneity (I2 = 99.36%, df = 132, p < 0.0001) was largely attributable to the methods used to detect injury (R2 = 44.77%, p < 0.000) with cell death assays detecting greater injury than survival assays (− 71 vs − 47%, R2 = 28.64%, p < 0.000). Seventy-four percent of publications provided no description of differentiation status, but in the 26% that did, undifferentiated cells were susceptible to greater injury (R2 = 4.13%, p < 0.047). One hundred and sixty-nine interventions improved average survival by 34.67% (p < 0.0001). Eighty-eight comparisons using oxygen-glucose deprivation found both benefit and harm, but studies using glutamate and H2O2 injury reported only improvement. In studies using glucose deprivation, intervention generally worsened outcome. There was insufficient data to rank individual interventions, but of the studies reporting greatest improvement (> 90% effect size), 7/13 were of herbal medicine constituents (24.85% of the intervention dataset). We conclude that surprisingly little is known of the human neuronal response to ischaemic injury, and that the large impact of methodology on outcome indicates that further model validation is required. Lack of evidence for randomisation, blinding or power analysis suggests that the intervention data is at substantial risk of bias.Electronic supplementary materialThe online version of this article (10.1007/s12975-018-0620-4) contains supplementary material, which is available to authorized users.

Genistein protects against amyloid‐beta‐induced toxicity in SH‐SY5Y cells by regulation of Akt and Tau phosphorylation

“…Since there are several studies using this cell line as an in vitro model for neurodegenerative disorders (Liu et al, 2018;Murillo et al, 2017;Xicoy, Wieringa, & Martens, 2017), particularly for investigation of Aβ toxicity and drug screening (Jämsä, Belda, Edlund, & Lindström, 2011;Lattanzio, Carboni, Carretta, Candeletti, & Romualdi, 2016;Yuan et al, 2017), our first objective was to compare the effect of the peptide on undifferentiated and differentiated cells. SH-SY5Y are neuroblast-like cells that can be differentiated into a mature neuronal phenotype using several differentiating agents, including RA, phorbol esters, and neurotrophins (Kovalevich & Langford, 2013).…”

Neuroprotective effects of human amniotic fluid stem cells-derived secretome in an ischemia/reperfusion model

“…Differentiated SH-SY5Y are widely accepted for in vitro experiments requiring neuronal-like cells. 17…”

Curcumin exerts protective effects against hypoxia‑reoxygenation injury via the enhancement of apurinic/apyrimidinic endonuclease�1 in SH‑SY5Y cells: Involvement of the PI3K/AKT pathway

“…The present study was undertaken to determine the roles of APE1 in the protective effects of curcumin against cerebral I/R injury, as well as to identify the molecular mechanisms through which curcumin affects SH-SY5Y neuronal cells subjected to oxygen-glucose deprivation/reperfusion (OGd/R), a commonly used in vitro model of cerebral I/R injury (24,25). It was observed that curcumin protected the SY-SH5Y cells against OGd/R injury by upregulating APE1 expression, which is associated with the regulation of the phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signaling pathway.…”